Virtus Family Office’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-47,121
Closed -$2.72M 47
2024
Q3
$2.72M Sell
47,121
-92
-0.2% -$4.97K 3.58% 9
2024
Q2
$2.29M Buy
47,213
+4,779
+11% +$231K 3.12% 10
2024
Q1
$2.06M Buy
42,434
+2,073
+5% +$101K 3.29% 15
2023
Q4
$2.01M Sell
40,361
-2,216
-5% -$108K 3.36% 11
2023
Q3
$2.28M Buy
42,577
+4,737
+13% +$253K 4.15% 9
2023
Q2
$2.04M Sell
37,840
-15,062
-28% -$810K 3.78% 9
2023
Q1
$2.88M Buy
52,902
+279
+0.5% +$13.6K 5.68% 6
2022
Q4
$2.55M Buy
52,623
+18,525
+54% +$813K 5.69% 5
2022
Q3
$1.32M Buy
+34,098
New +$1.52M 3.37% 7

Other funds holding SNY

Virtus Family Office's SNY Position: Q4 2024 in Review

Virtus Family Office sold out of Sanofi (SNY) in Q4 2024, closing a stake of 47,121 shares — an estimated $2.72M sold.

Virtus Family Office first reported a position in SNY in Q3 2022 and held it in 9 quarters. The position peaked at $2.88M in Q1 2023. 731 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

  • Virtus Family Office reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
  • Virtus Family Office sold 47,121 Sanofi shares in Q4 2024, an estimated $2.72M.
  • Virtus Family Office first reported a position in Sanofi in Q3 2022 and held it in 9 quarters.
  • Virtus Family Office's Sanofi position peaked at $2.88M in Q1 2023.
  • 731 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Virtus Family Office's 13F filing for Q4 2024, filed 11 Feb 2025.